374886-53-0

Basic information

• Product Name: 3-[3-(3-Methoxypropyl)-5-(6-phenylpyridin-3-yl)-4H-1,2,4-triazol-4-yl]-2-methylbenzamide
• Synonyms: 3-[3-(3-Methoxypropyl)-5-(6-phenylpyridin-3-yl)-4H-1,2,4-triazol-4-yl]-2-methylbenzamide
• CAS NO: 374886-53-0
• Molecular Weight: 427.506
• Mol File: 374886-53-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3-[3-(3-Methoxypropyl)-5-(6-phenylpyridin-3-yl)-4H-1,2,4-triazol-4-yl]-2-methylbenzamide(CAS DataBase Reference)
• NIST Chemistry Reference: 3-[3-(3-Methoxypropyl)-5-(6-phenylpyridin-3-yl)-4H-1,2,4-triazol-4-yl]-2-methylbenzamide(374886-53-0)
• EPA Substance Registry System: 3-[3-(3-Methoxypropyl)-5-(6-phenylpyridin-3-yl)-4H-1,2,4-triazol-4-yl]-2-methylbenzamide(374886-53-0)

Safety Data

• Hazardous Substances Data: 374886-53-0(Hazardous Substances Data)

Upstream product

• 374889-30-2 3-amino-2-methylbenzamide 
• 76-26-6 camphor-10-sulfonic acid 

Downstream Products

• 374886-54-1 3-[3-(3-methoxypropyl)-5-(6-phenylpyridin-3-yl)-4H-1,2,4-triazol-4-yl]-2-methylbenzonitrile 

Relevant articles and documents

Triazole derivatives

The invention relates to a triazole derivative with an activity inhibiting glycine transporter and for use as a pharmaceutical drug, and a novel triazole derivative. The inventive triazole derivative has an excellent activity inhibiting glycine transporter and is useful as a therapeutic agent of dementia, schizophrenia, cognitive disorders, or cognitive disorders involved in various diseases such as Alzheimer disease, Parkinson's disease, or Huntington disease or the like, or spasm involved in diseases such as nerve degenerative diseases and cerebrovascular disorders, or the like. Particularly, the pharmaceutical drug is useful for the amelioration of learning disability of dementia and the like.